注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Polypid Ltd是一家处于临床阶段的以色列生物制药公司。该公司专注于开发、生产和商业化可改善手术效果的新型局部派发疗法。主要产品是PLEX技术。该技术作用于手术位置来确保药物的可控连续输送。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Chaim Hurvitz | 61 | - | Director |
Yafit Stark | 69 | 2008 | Clinical Development Strategy Advisor |
Yechezkel Barenholz | 83 | 2008 | Independent Director |
Moshe Salai | - | - | Member of Scientific Advisory Board |
Erez Kachel | - | - | Member of Scientific Advisory Board |
Hartzell V. Schaff | - | 2017 | Member of Scientific Advisory Board |
Robert Benjamin Stein | 73 | 2020 | Independent Director |
Dikla Czaczkes Akselbrad | 51 | 2014 | CEO & Director |
Itzhak Krinsky | 71 | 2019 | Independent Director |
Jacob Harel | 69 | 2017 | Independent Chairman |
Mitchel S. Berger | - | 2022 | Member of Scientific Advisory Board |
Joseph BenAmram | 60 | 2023 | Independent Director |
Nir Dror | 48 | 2020 | Independent Director |
Frederick Lang | - | 2021 | Member of Scientific Advisory Board |
Nurit Tweezer-Zaks | 58 | 2023 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核